Home / 2019 / July / 01

Daily Archives: July 1, 2019

Philips Foundation publishes 2018 Annual Report

July 1, 2019

Amsterdam, the Netherlands The Philips Foundation, established by Royal Philips (NYSE: PHG; AEX: PHIA) as the central platform for Philips’ CSR activities, today announced publication of its 2018 Annual Report. The report highlights the Foundation’s solid progress in delivering on its commitment to reduce health inequality through meaningful innovation. This includes support for local NGO projects, collaboration with international organizations, and support for social entrepreneurs seeking to implement innovative healthcare solutions. Via the Foundation, Philips also focuses its workforce’s volunteering activities on a single global healthcare issue to achieve greater impact.

Building on its commitment to help solve some of the world’s most difficult healthcare challenges through innovation and collaboration, the Philips Foundation deliberately steered away from traditional donations in 2018. Instead, it teamed up with complementary partners, such as national Red Cross societies, UNICEF, ICRC, Save the Children and Amref, and with specific social entrepreneurs, resulting in the launch of 40 exciting new projects that explore new models of access to care to strengthen healthcare systems, improve outcomes, and reduce the cost of care.

“Standing shoulder to shoulder with our partners and of course Philips’ workforce, the Philips Foundation focuses on providing high-quality healthcare to communities lacking affordable and sustainable facilities,” said Margot Cooijmans, Director Philips Foundation. “In developing and deploying innovative solutions the Philips Foundation leverages the heads and hands, skills and technologies of Philips and its employees worldwide, to serve the health and well-being of disadvantaged people. To date, over 150 projects are running, improving the lives of more than 10 million people.”

Social entrepreneurship – accelerating access to care in collaboration with Ashoka
The Philips Foundation and Ashoka, the largest global network of leading social entrepreneurs, have completed the first year of a three-year collaboration to increase access to healthcare around the world. By connecting leaders in Philips with innovative social entrepreneurs, the aim is to optimally leverage business capabilities and achieve greater impact. In 2018, five new social entrepreneurs were selected, all committed to accelerating access to healthcare in underserved communities of Africa, Asia, and Latin America. Combining the business strengths of Philips and the system-changing capabilities of social entrepreneurs will allow the co-creation of solutions and the establishment of win-win partnerships to reduce health inequality and build sustainable access to primary healthcare.

Employee volunteering – making an impact on a key global access-to-healthcare issue
Through its employee team-volunteering program, the Philips Foundation provides a platform for more than 75,000 Philips employees to volunteer and make an impact on a key global access-to-healthcare issue. The focused goal for 2018 and 2019 is to reduce childhood pneumonia – a respiratory disease that can be relatively easily prevented, diagnosed and treated. Working closely with its strong network of NGOs, including Amref, the UN Foundation, Save the Children and the Red Cross, the Philips Foundation has identified impactful challenges, such as brain challenges, hands-on challenges and fundraising opportunities, that support the fight against childhood pneumonia. In 2018, the Philips Foundation facilitated deployment of up to 4,800 hours of volunteer work.

To read the Philips Foundation’s full Annual Report, please click here.

For further information, please contact:

Koen Joosse
Philips Foundation
Tel.: +31 6 1339 2233
E-mail: koen.joosse@philips.com

About the Philips Foundation
The Philips Foundation is a registered charity that was established in July 2014 as the central platform for Philips’ CSR activities. Reflecting our commitment to United Nations Sustainable Development Goals 3 (Ensure healthy lives and promote well-being for all at all ages) and 17 (Revitalize the global partnership for sustainable development), the mission of the Foundation is to reduce healthcare inequality by providing access to quality healthcare for disadvantaged communities. We do this by deploying Philips’ expertise, innovative products and solutions, by collaborating with key partners around the world and by providing financial support for collaborative activities. More information on the Philips Foundation can be found at https://www.philips-foundation.com.

Attachment

Nanobiotix announces new organizational structure as the company enters its next stage after first european market approval

NANOBIOTIX ANNOUNCES NEW ORGANIZATIONAL STRUCTURE AS THE COMPANY ENTERS ITS NEXT STAGE AFTER FIRST EUROPEAN MARKET APPROVAL

  • Recently appointed Chief Medical Officer (CMO) Edwina Baskin-Bey, M.D., will join the Executive Board
  • Anne-Juliette Hermant, M.A., will be appointed Chief People Officer (CPO) and will join the Executive Board
  • Former CMO Elsa Borghi, M.D., will lead innovation and drug discovery for the company while leaving the Executive Board to focus on her new responsibilities
  • Chief Business Officer (CBO) Bernd Muehlenweg, Ph.D., will step down from the Executive Board and  exit the company
  • Patrick Tricoli, Pharm.D. M.B.A., will remain CEO of Nanobiotix Corp, the company’s U.S. affiliate, and also take on a new role as the Global Head of Business Development
  • Brandon Owens will be appointed Vice President (VP) of Strategic Marketing and Corporate Communications        

“As we enter our next stage as a company after receiving our first European market approval for Hensify® (NBTXR3) in Soft Tissue Sarcoma, we feel it is necessary to ensure we are optimally structured for continued success. As such, we are delighted to welcome our newcomers and congratulate those stepping into new roles. I also want to personally thank Dr. Bernd Muehlenweg, without whom we never would have achieved the business successes we have realized to this point. We are in a new era at Nanobiotix and I am confident these changes will serve to accelerate our growth.” – Laurent Levy, CEO of Nanobiotix            

Paris, France and Cambridge, Massachusetts, USA, July 1, 2019 – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced organizational  changes to align with strategic priorities post European market approval for Hensify® (NBTXR3). The changes aim to reinforce necessary competencies as strategic priorities evolve, and to help accelerate the company’s longstanding mission to significantly improve outcomes for patients.

New C-level Appointments and Executive Board Members
Recently appointed CMO Dr. Edwina Baskin-Bey will join the Executive Board. Ms. Anne-Juliette Hermant will be appointed CPO and will join the Executive Board as well.

C-level and Executive Board Departures
As mentioned in a previous press release, former CMO Dr. Elsa Borghi will leave the Executive Board to take on a new function leading innovation and drug discovery. CBO Dr. Bernd Muehlenweg will step down from the Executive Board and exit the company.

New Management Appointments and Responsibilities
Dr. Patrick Tricoli will remain CEO of Nanobiotix Corp, the company’s U.S. affiliate, while also taking on a new role as Global Head of Business Development. Mr. Brandon Owens will join Nanobiotix as its newly appointed VP of Strategic Marketing and Corporate Communications.

Newcomer Biographical Details

Ms. Anne-Juliette Hermant
Anne-Juliette Hermant brings over 14 years of experience in HR, talent management and development, acquired across various entities at AXA. Ms. Hermant worked at AXA Partners for 3 years as Global Head of Talent, Development, Culture and Corporate Responsibility.

Before AXA Partners, Anne-Juliette served as Chief Learning Officer of the AXA Group and was the Founder and Head of the AXA Research Fund, a €100 million fund created by the AXA Group to support frontier science in all fields related to an understanding of the risks faced by human society.

Anne-Juliette was born in Strasbourg, France and grew up between the French overseas territories of Guyane, Martinique and Guadeloupe. She relocated to Lyon and then to Paris to pursue her studies and has remained in the city throughout her career.

Anne-Juliette graduated from the Ecole Normale Supérieure and studied Politics at Sciences Po Paris. She holds an Agregation and an M.A. in French literature.

Mr. Brandon Owens
Brandon Owens is a career communications professional that most recently functioned as a Vice President on the Citigroup account at Publicis New York. Mr. Owens was responsible for Citi’s global reputation management communications and focused on integrated campaigns meant to influence policy decisions relevant to banking in over 100 different countries.

Prior to Publicis, Brandon worked at agencies in both New York and Chicago, leading accounts including Procter and Gamble, Verizon Wireless, and Diageo.

Originally, Brandon comes from the Washington, D.C. area of the United States. After starting his career in sales for a small software firm in Baltimore, Maryland, he moved to Chicago to begin his career in advertising. From there he moved to New York City where he presently resides.

Brandon received his B.S. in Business from the Robert H. Smith School of Business at the University of Maryland.

About NANOBIOTIX: www.nanobiotix.com

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotix’s first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Company’s headquarters are in Paris, France, with a U.S. affiliate in Cambridge, MA, and European affiliates in Spain and Germany.

Contacts

Nanobiotix

Communications Department
+33 (0)1 40 26 07 55
+1 (617) 852-4835
contact@nanobiotix.com

 

Investor Relations Department
+33 (0)1 79 97 29 99
+1 (646) 241-4400
investors@nanobiotix.com

Media relations

France – Springbok Consultants
Marina Rosoff
+33 (0)6 71 58 00 34
marina@springbok.fr

United States – RooneyPartners
Marion Janic
+1 (212) 223-4017
mjanic@rooneyco.com

 

Disclaimer

This press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the reference document of Nanobiotix registered with the French Financial Markets Authority (Autorité des Marchés Financiers) under number R.19-018 on April 30, 2019 (a copy of which is available on www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

Attachment

McDonald’s Malaysia introduces Portuguese Chicken Burger

PETALING JAYA, McDonald’s Malaysia is now taking Malaysians on an exciting taste journey to another corner of the world with the brand new Portuguese Chicken Burger.

Its marketing director, Eugene Lee said, inspired by the sights, sounds and flavours of Portugal, the burger was the second exciting menu item to be introduced as part of McDonald’s Malaysia’s ‘Discover the World 2019’ campaign.

Over the years, we have taken our customers on exciting taste adventures to countries such as Brazil, Mexico, Korea and Thailand by infusing their unique flavours into the menu here in Malaysia through our campaigns, he said at the launch of the burger, here, today.

The burger features a juicy fried chicken patty, dipped in a unique piri-piri sauce, served with a bed of mixed vegetables and fresh lettuce, all sandwiched between a brand new chilli flake bun.

When it comes to innovative menu items, McDonald’s always strives to delight and surprise customers with new explosive flavours and this burger definitely offers a taste experience that is unlike anything we have introduced before, said Lee.

The Portuguese Chicken Burger set meal is served with French Fries and either a Fanta Grape McFreeze or regular Coke, and is priced from RM16.99 for a limited time.

To add more excitement, from July 4 until 24, McDonald’s Malaysia will be introducing a new augmented reality game called Catching Nonando, in which customers will need to ‘catch’ as many Nonando Chickens as they can in 60 seconds to collect points.

Customers will be instantly rewarded with a discount on the burger, depending on how many Nonandos they catch and stand a chance to walk away with up to 50,000 AirAsia BIG Points.

To play the game, customers need to click on the Facebook link available at McDonald’s Malaysia corporate website or official Facebook page.

Source: BERNAMA (News Agency)

Ranhill Water Services secures RM151 mln contract in Johor

KUALA LUMPUR, Ranhill Holdings Bhd, through wholly-owned subsidiary Ranhill Water Services Sdn Bhd (RWS), has been awarded a two-year contract worth RM151.1 million to reduce non-revenue water (NRW) in Johor

Ranhill said the project — the fifth successive NRW project in Johor secured by RWS through the competitive open tender process since 2011 — would be undertaken immediately and completed by June 30, 2021.

The work scope covers the establishment of new district meter areas (DMAs) and re-establishment of existing DMAs as well as DMA metres monitoring, maintenance and verification, among others.

The project would be funded by government-owned Pengurusan Aset Air Bhd (PAAB) as part of its capital development expenditure for Johor, it said in a filing with Bursa Malaysia.

The repayment would be made by Johor’s sole licensed water operator Ranhill SAJ Sdn Bhd, which is an 80 per cent-owned subsidiary of Ranhill, via the payment of lease rental charges to PAAB over the next 45 years (beginning from the completion date).

Ranhill said the project, to be undertaken over the next 24 months, would contribute positively to the earnings of RWS and Ranhill for the financial years ending Dec 31, 2019 to 2021.

Ranhill SAJ, which operates more than 40 water treatment plants, is the Ranhill group’s main revenue contributor while RWS focuses mainly on management of NRW.

RWS has been undertaking NRW projects in Johor in a holistic manner since its inception in 2005 and has reduced NRW in Johor from over 37 per cent in 2005 to 22.85 per cent as at April 30, 2019.

Apart from Johor, RWS has successfully secured NRW reduction projects through competitive open tender process in several states such as Melaka, Kedah, Kelantan, Terengganu and Pahang.

Source: BERNAMA (News Agency)

Sugar tax implementation poised to reduce medical costs — MATA

KUALA LUMPUR, The implementation of sugar tax in Malaysia which kicked off today will not generate significant revenue for the government but will help in reducing the medical cost arising from the unhealthy habits of consuming excessive sugar, said the Malaysian Association of Tax Accountants (MATA).

President Datuk Abdul Aziz Abu Bakar said the existing excise duty imposed on cigarettes, alcohol and others was meant to avoid health issues among the people.

The government will not get much revenue from the manufacturers because in any country that introduced soda tax, the manufacturers will change their product mix so that they can produce products that can avoid from having to pay the sugar tax, he said to Bernama today.

The people must understand that they (the government) has taken (this) into consideration and the government has given ample time for the business community to adjust themselves and the opportunity for them to plan their strategy in terms of products and production methods.

The sugar tax has a negative impactbut positive in the perspective of preventive medical cost, meaning we can create a society that takes care of their sugar intake (and health), he said.

Abdul Aziz said this would mean that Malaysians will have a healthy lifestyle, as individually they would reduce spending on sugar and over the long term, the government would be able to save on hospitalisation cost.

Indirectly, he said, the price of sugar-related products would increase, and manufacturers would not absorb the additional cost due to the tax, and definitely, the cost would be passed on to the retailers and consumers.

On Bursa Malaysia today, Nestle Malaysia Bhd ended as the top loser, declining 70 sen to RM148.40, while Fraser and Neave Holdings Bhd fell 16 sen to RM34.40 and Dutch Lady Milk Industries Bhd edged down 10 sen to RM63.90.

Abdul Aziz said the impact of the sugar tax on the capital market would be for the short to medium term as it is an adjustment period.

Generally, people will see a drop in sentiment, that’s why stock market is a bit down, he said.

The government must explain this move to the people and ensure that they understood fully that the introduction of the sugar tax would not generate a significant income for the country but is an alternative way to reduce sugar consumption.

Source: BERNAMA (News Agency)

AirAsia plans to offer more routes via LTAM

MELAKA, Low-cost carrier AirAsia Bhd (AirAsia) aims to offer more routes from the Melaka International Airport (LTAM) in addition to the direct flight between it and Penang launched today, said chief executive officer Riad Asmat.

He said this long-term goal would, however, hinge on passenger demand for the new routes and the cooperation of various parties, including the Melaka state government, in promoting the routes.

According to him, Melaka is one of the two most popular destinations among foreign passengers flying on the airline other than Penang, as both states share a few similarities in terms of culture and history that are recognised by the United Nations Educational, Scientific and Cultural Organisation (Unesco) and serve as the main attractions for tourists.

In terms of new destinations via LTAM, there are many potential locations in the long term but we will do studies before finalising them. This will take three to six months.

We believe Melaka itself has potential. Ticket sales recorded for the two-way flights between Melaka and Penang launched today were encouraging with more than 90 per cent of seats taken up, he told reporters after the welcoming ceremony for the inaugural Melaka-Penang-Melaka flight at LTAM today witnessed by Chief Minister Adly Zahari.

The maiden flight, which used an Airbus A320 to ferry 175 passengers, left the Penang International Airport at 1.20 pm and landed at LTAM at 2.25 pm.

Riad said the launch of the route would not only help boost the local tourism industry but also contribute towards the long-term economic growth of the two Unesco World Heritage sites.

Through the route, the people of Melaka who want to fly to Sabah and Sarawak or other destinations in ASEAN can take the appropriate flights via our hub in Penang. Melaka is AirAsia’s sixth domestic destination in AirAsia and this marks the 14th route from our Penang hub,” he said.

The daily direct flights, which depart from Penang to Melaka at 1.20 pm and from Melaka to Penang at 2.50 pm priced, are priced at RM79 for one-way travel.

Meanwhile, Adly said the new AirAsia flight at LTAM would help the state government in ensuring the airport function at an optimal level and be of service to the people.

He said it would contribute to the growth in tourists visiting Melaka, help to promote the state as one of Asia’s leading destinations and give a boost to Visit Melaka Year 2019.

In the first quarter of this year, Melaka welcomed 4.79 million tourists, comprising 3.41 million local tourists and 1.38 million foreign tourists. With the latest service offered by AirAsia, we are confident of achieving the target of 20 million tourists visiting Melaka this year, he said.

Source: BERNAMA (News Agency)

OIB’s unit to buy SDP’s land for RM40.11 mln

KUALA LUMPUR, Oriental Interest Bhd’s (OIB) subsidiary, Myra Land Sdn Bhd is buying Sime Darby Plantation Bhd’s (SDP) land in Kuala Langat, Selangor for RM40.11 million.

In a filing with Bursa Malaysia today, it said both parties had entered into a sale and purchase agreement for the proposed acquisition of 42.1 hectares plot of land.

OIB said the purchase would be funded by internally generated funds and or bank borrowings.

“The proposed acquisition is in line with the group’s strategic planning to leverage its strength in property development and construction to develop the land complementary the group’s existing development in the Klang Valley.

“It is also in line with the group’s overall plan to increase its land bank in good areas, given the opportunities available in the current market condition,” it added.

The acquisition is expected to contribute positively to the future earnings of the group.

Source: BERNAMA (News Agency)